MedPath

ViGeneron GmbH

ViGeneron GmbH logo
πŸ‡©πŸ‡ͺGermany
Ownership
Holding
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://www.vigeneron.com

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

Phase 1
Recruiting
Conditions
Retinitis Pigmentosa
Interventions
First Posted Date
2024-03-04
Last Posted Date
2025-03-28
Lead Sponsor
ViGeneron GmbH
Target Recruit Count
6
Registration Number
NCT06291935
Locations
πŸ‡©πŸ‡ͺ

Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany

Β© Copyright 2025. All Rights Reserved by MedPath